Recent Advances in Cardiac Resynchronization Therapy: Current Treatment and Future Direction

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Cardiac Resynchronization Therapy (CRT) is a key treatment for heart failure, reducing morbidity and mortality in selected patients.
• CRT improves outcomes by synchronizing ventricular contractions, reducing hospitalizations, and optimizing clinical results.
• A significant portion of patients do not respond to traditional CRT, necessitating alternative approaches.

Purpose of the Study:

• To review recent clinical trial findings and systematic reviews on Cardiac Resynchronization Therapy (CRT).
• To explore novel CRT modalities like leadless pacemakers and conduction system pacing (CSP).
• To provide insights that will guide future patient care strategies in heart failure management.

Main Methods:

• Comprehensive literature review of recent CRT clinical trials.
• Systematic review of published studies on CRT outcomes and novel pacing techniques.
• Analysis of data focusing on patient selection, response rates, and emerging technologies.

Main Results:

• CRT is established for heart failure with reduced ejection fraction and wide QRS duration.
• High rates of CRT non-response persist, driving innovation in device development.
• Leadless CRT-P and CSP devices show promise for improving patient selection and outcomes.

Conclusions:

• CRT remains a cornerstone in heart failure management for appropriate candidates.
• Emerging technologies like leadless CRT and CSP are crucial for addressing CRT non-responders.
• Future research should focus on optimizing patient selection and refining these advanced pacing strategies.